{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:48:40Z","timestamp":1789620520587,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/bmt.2013.114","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T10:38:34Z","timestamp":1376303914000},"page":"138-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis"],"prefix":"10.1038","volume":"49","author":[{"given":"D","family":"Teschner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Marandiuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,12]]},"reference":[{"key":"BFbmt2013114_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14653240510018172","volume":"7","author":"S Mielke","year":"2005","unstructured":"Mielke S, Solomon SR, Barrett AJ . Selective depletion strategies in allogeneic stem cell transplantation. Cytotherapy 2005; 7: 109\u2013115.","journal-title":"Cytotherapy"},{"key":"BFbmt2013114_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MOH.0b013e3283582340","volume":"19","author":"R Handgretinger","year":"2012","unstructured":"Handgretinger R . Negative depletion of CD3(+) and TcRalphabeta(+) T cells. Curr Opin Hematol 2012; 19: 434\u2013439.","journal-title":"Curr Opin Hematol"},{"key":"BFbmt2013114_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1182\/blood-2006-03-005769","volume":"109","author":"RG Meyer","year":"2007","unstructured":"Meyer RG, Britten CM, Wehler D, Bender K, Hess G, Konur A et al. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation. Blood 2007; 109: 374\u2013382.","journal-title":"Blood"},{"key":"BFbmt2013114_CR4","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1182\/blood-2003-12-4431","volume":"104","author":"AE Foster","year":"2004","unstructured":"Foster AE, Marangolo M, Sartor MM, Alexander SI, Hu M, Bradstock KF et al. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion. Blood 2004; 104: 2403\u20132409.","journal-title":"Blood"},{"key":"BFbmt2013114_CR5","first-page":"20","volume":"14","author":"BJ Chen","year":"2008","unstructured":"Chen BJ . Allogeneic memory T cell response. Biol Blood Marrow Transplant 2008; 14: 20\u201322.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2013114_CR6","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.3324\/haematol.2010.037481","volume":"96","author":"E Distler","year":"2011","unstructured":"Distler E, Bloetz A, Albrecht J, Asdufan S, Hohberger A, Frey M et al. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells. Haematologica 2011; 96: 1024\u20131032.","journal-title":"Haematologica"},{"key":"BFbmt2013114_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3324\/haematol.2011.052597","volume":"97","author":"P Kleemann","year":"2012","unstructured":"Kleemann P, Distler E, Wagner EM, Thomas S, Klobuch S, Aue S et al. Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation. Haematologica 2012; 97: 874\u2013882.","journal-title":"Haematologica"},{"key":"BFbmt2013114_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0047-6374(95)01691-0","volume":"86","author":"A Cossarizza","year":"1996","unstructured":"Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P et al. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory. Mech Ageing Dev 1996; 86: 173\u2013195.","journal-title":"Mech Ageing Dev"},{"key":"BFbmt2013114_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/cyto.a.20643","volume":"73","author":"V Appay","year":"2008","unstructured":"Appay V, van Lier RA, Sallusto F, Roederer M . Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008; 73: 975\u2013983.","journal-title":"Cytometry A"},{"key":"BFbmt2013114_CR10","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","volume":"108","author":"P Hoffmann","year":"2006","unstructured":"Hoffmann P, Eder R, Boeld TJ, Doser K, Piseshka B, Andreesen R et al. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006; 108: 4260\u20134267.","journal-title":"Blood"},{"key":"BFbmt2013114_CR11","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","volume":"115","author":"R Seggewiss","year":"2010","unstructured":"Seggewiss R, Einsele H . Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010; 115: 3861\u20133868.","journal-title":"Blood"},{"key":"BFbmt2013114_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1084\/jem.20040613","volume":"202","author":"M Cobbold","year":"2005","unstructured":"Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, Osman H et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005; 202: 379\u2013386.","journal-title":"J Exp Med"},{"key":"BFbmt2013114_CR13","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","volume":"116","author":"T Feuchtinger","year":"2010","unstructured":"Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116: 4360\u20134367.","journal-title":"Blood"},{"key":"BFbmt2013114_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tmrv.2005.04.002","volume":"19","author":"MM Waanders","year":"2005","unstructured":"Waanders MM, Roelen DL, Brand A, Claas FH . The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Transfus Med Rev 2005; 19: 281\u2013287.","journal-title":"Transfus Med Rev"},{"key":"BFbmt2013114_CR15","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.4049\/jimmunol.166.11.6693","volume":"166","author":"SK Joshi","year":"2001","unstructured":"Joshi SK, Suresh PR, Chauhan VS . Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology. J Immunol 2001; 166: 6693\u20136703.","journal-title":"J Immunol"},{"key":"BFbmt2013114_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1084\/jem.179.4.1155","volume":"179","author":"SR Burrows","year":"1994","unstructured":"Burrows SR, Khanna R, Burrows JM, Moss DJ . An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 1994; 179: 1155\u20131161.","journal-title":"J Exp Med"},{"key":"BFbmt2013114_CR17","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","volume":"115","author":"AL Amir","year":"2010","unstructured":"Amir AL, D'Orsogna LJ, Roelen DL, van Loenen MM, Hagedoorn RS, de Boer R et al. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010; 115: 3146\u20133157.","journal-title":"Blood"},{"key":"BFbmt2013114_CR18","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/TP.0b013e31818810d6","volume":"86","author":"M Nonn","year":"2008","unstructured":"Nonn M, Herr W, Khan S, Todorova M, Link I, Thies J et al. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering. Transplantation 2008; 86: 1427\u20131435.","journal-title":"Transplantation"},{"key":"BFbmt2013114_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1084\/jem.190.5.705","volume":"190","author":"MJ Pittet","year":"1999","unstructured":"Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Li\u00e9nard D, Lejeune F et al. High frequencies of naive Melan-A\/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 1999; 190: 705\u2013715.","journal-title":"J Exp Med"},{"key":"BFbmt2013114_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.exphem.2007.12.011","volume":"36","author":"E Distler","year":"2008","unstructured":"Distler E, Wolfel C, Kohler S, Nonn M, Kaus N, Schnurer E et al. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD\/SCID IL2Rgamma(null) mice. Exp Hematol 2008; 36: 451\u2013463.","journal-title":"Exp Hematol"},{"key":"BFbmt2013114_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00262-010-0936-8","volume":"60","author":"J Albrecht","year":"2011","unstructured":"Albrecht J, Frey M, Teschner D, Carbol A, Theobald M, Herr W et al. IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype. Cancer Immunol Immunother 2011; 60: 235\u2013248.","journal-title":"Cancer Immunol Immunother"},{"key":"BFbmt2013114_CR22","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1182\/blood-2009-12-260539","volume":"115","author":"M Bleakley","year":"2010","unstructured":"Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T et al. Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood 2010; 115: 4923\u20134933.","journal-title":"Blood"},{"key":"BFbmt2013114_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3324\/haematol.2010.039099","volume":"96","author":"I Jedema","year":"2011","unstructured":"Jedema I, van de Meent M, Pots J, Kester MG, van der Beek MT, Falkenburg JH . Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells. Haematologica 2011; 96: 1204\u20131212.","journal-title":"Haematologica"},{"key":"BFbmt2013114_CR24","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1182\/blood-2010-10-312751","volume":"117","author":"S Dutt","year":"2011","unstructured":"Dutt S, Baker J, Kohrt HE, Kambham N, Sanyal M, Negrin RS et al. CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD. Blood 2011; 117: 3230\u20133239.","journal-title":"Blood"},{"key":"BFbmt2013114_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12185-011-0781-3","volume":"93","author":"K Rezvani","year":"2011","unstructured":"Rezvani K . Peptide vaccine therapy for leukemia. Int J Hematol 2011; 93: 274\u2013280.","journal-title":"Int J Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2013114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2013114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2013114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T16:07:16Z","timestamp":1648051636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2013114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFbmt2013114"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2013.114","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,12]]},"assertion":[{"value":"29 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kirsten Langeveld is employee of the company Miltenyi Biotec, which provided the CD45RA depletion reagents free of charge. Miltenyi Biotec did not influence the design of the study. The company was also not involved in collection and analysis of data as well as the decision to publish the results. All authors including Kirsten Langeveld declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}